Endothelium-specific sepiapterin reductase deficiency in DOCA-salt hypertension

Ji Youn Youn, Ting Wang, John Blair, Karine M. Laude, Jeong Ho Oak, Louise A. McCann, David G. Harrison, Hua Cai

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The endothelial nitric oxide synthase (eNOS) requires tetrahydrobiopterin (H 4B) as a cofactor and, in its absence, produces superoxide (O 2 -) rather than nitric oxide (NO), a condition referred to as eNOS uncoupling. DOCA-salt-induced hypertension is associated with H 4B oxidation and uncoupling of eNOS. The present study investigated whether administration of sepiapterin or H 4B recouples eNOS in DOCA-salt hypertension. Bioavailable NO detected by electron spin resonance was markedly reduced in aortas of DOCA-salt hypertensive mice. Preincubation with sepiapterin (10 μmol/l for 30 min) failed to improve NO bioavailability in hypertensive aortas while it augmented NO production from control vessels, implicating a hypertension-associated deficiency in sepiapterin reductase (SPR), the rate-limiting enzyme for sepiapterin conversion to H 4B. Indeed, a decreased SPR expression was observed in aortic endothelial cells, but not in endothelium-denuded aortic remains, implicating an endothelium-specific SPR deficiency. Administration of hypertensive aortas with H 4B (10 μmol/l, 30 min) partially restored vascular NO production. Combined administration of H 4B and the NADPH oxidase inhibitor apocynin (100 μmol/l, 30 min) fully restored NO bioavailability while reducing O 2 - production. In angiotensin II-induced hypertension, however, aortic endothelial SPR expression was not affected. In summary, administration of sepiapterin is not effective in recoupling eNOS in DOCA-salt hypertension, due to an endothelium-specific loss in SPR, whereas coadministration of H 4B and apocynin is highly efficient in recoupling eNOS. This is consistent with our previous observations that in angiotensin II hypertension, endothelial deficiency in dihydro-folate reductase is alternatively responsible for uncoupling of eNOS. Taken together, these data indicate that strategies specifically targeting at different H 4B metabolic enzymes might be necessary in restoring eNOS function in different types of hypertension.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume302
Issue number11
DOIs
StatePublished - Jun 1 2012
Externally publishedYes

Fingerprint

Desoxycorticosterone Acetate
Nitric Oxide Synthase Type III
Endothelium
sepiapterin reductase
Salts
Hypertension
Nitric Oxide
Aorta
Angiotensin II
Biological Availability
Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency
NADPH Oxidase
Electron Spin Resonance Spectroscopy
Enzymes
Folic Acid
Superoxides
Blood Vessels
Oxidoreductases
Endothelial Cells
sepiapterin

Keywords

  • Deoxycorticosterone acetate
  • Endothelial nitric oxide synthase uncoupling
  • Nitric oxide
  • Sepiapterin reductase
  • Superoxide
  • Tetrahydrobiopterin
  • Vascular reduced nicotinamide adenine dinucleotide phosphatase

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Endothelium-specific sepiapterin reductase deficiency in DOCA-salt hypertension. / Youn, Ji Youn; Wang, Ting; Blair, John; Laude, Karine M.; Oak, Jeong Ho; McCann, Louise A.; Harrison, David G.; Cai, Hua.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 302, No. 11, 01.06.2012.

Research output: Contribution to journalArticle

Youn, Ji Youn ; Wang, Ting ; Blair, John ; Laude, Karine M. ; Oak, Jeong Ho ; McCann, Louise A. ; Harrison, David G. ; Cai, Hua. / Endothelium-specific sepiapterin reductase deficiency in DOCA-salt hypertension. In: American Journal of Physiology - Heart and Circulatory Physiology. 2012 ; Vol. 302, No. 11.
@article{b53490302bd54bdb9e8f1240fa82920d,
title = "Endothelium-specific sepiapterin reductase deficiency in DOCA-salt hypertension",
abstract = "The endothelial nitric oxide synthase (eNOS) requires tetrahydrobiopterin (H 4B) as a cofactor and, in its absence, produces superoxide (O 2 -) rather than nitric oxide (NO), a condition referred to as eNOS uncoupling. DOCA-salt-induced hypertension is associated with H 4B oxidation and uncoupling of eNOS. The present study investigated whether administration of sepiapterin or H 4B recouples eNOS in DOCA-salt hypertension. Bioavailable NO detected by electron spin resonance was markedly reduced in aortas of DOCA-salt hypertensive mice. Preincubation with sepiapterin (10 μmol/l for 30 min) failed to improve NO bioavailability in hypertensive aortas while it augmented NO production from control vessels, implicating a hypertension-associated deficiency in sepiapterin reductase (SPR), the rate-limiting enzyme for sepiapterin conversion to H 4B. Indeed, a decreased SPR expression was observed in aortic endothelial cells, but not in endothelium-denuded aortic remains, implicating an endothelium-specific SPR deficiency. Administration of hypertensive aortas with H 4B (10 μmol/l, 30 min) partially restored vascular NO production. Combined administration of H 4B and the NADPH oxidase inhibitor apocynin (100 μmol/l, 30 min) fully restored NO bioavailability while reducing O 2 - production. In angiotensin II-induced hypertension, however, aortic endothelial SPR expression was not affected. In summary, administration of sepiapterin is not effective in recoupling eNOS in DOCA-salt hypertension, due to an endothelium-specific loss in SPR, whereas coadministration of H 4B and apocynin is highly efficient in recoupling eNOS. This is consistent with our previous observations that in angiotensin II hypertension, endothelial deficiency in dihydro-folate reductase is alternatively responsible for uncoupling of eNOS. Taken together, these data indicate that strategies specifically targeting at different H 4B metabolic enzymes might be necessary in restoring eNOS function in different types of hypertension.",
keywords = "Deoxycorticosterone acetate, Endothelial nitric oxide synthase uncoupling, Nitric oxide, Sepiapterin reductase, Superoxide, Tetrahydrobiopterin, Vascular reduced nicotinamide adenine dinucleotide phosphatase",
author = "Youn, {Ji Youn} and Ting Wang and John Blair and Laude, {Karine M.} and Oak, {Jeong Ho} and McCann, {Louise A.} and Harrison, {David G.} and Hua Cai",
year = "2012",
month = "6",
day = "1",
doi = "10.1152/ajpheart.00835.2011",
language = "English (US)",
volume = "302",
journal = "American Journal of Physiology",
issn = "0363-6143",
publisher = "American Physiological Society",
number = "11",

}

TY - JOUR

T1 - Endothelium-specific sepiapterin reductase deficiency in DOCA-salt hypertension

AU - Youn, Ji Youn

AU - Wang, Ting

AU - Blair, John

AU - Laude, Karine M.

AU - Oak, Jeong Ho

AU - McCann, Louise A.

AU - Harrison, David G.

AU - Cai, Hua

PY - 2012/6/1

Y1 - 2012/6/1

N2 - The endothelial nitric oxide synthase (eNOS) requires tetrahydrobiopterin (H 4B) as a cofactor and, in its absence, produces superoxide (O 2 -) rather than nitric oxide (NO), a condition referred to as eNOS uncoupling. DOCA-salt-induced hypertension is associated with H 4B oxidation and uncoupling of eNOS. The present study investigated whether administration of sepiapterin or H 4B recouples eNOS in DOCA-salt hypertension. Bioavailable NO detected by electron spin resonance was markedly reduced in aortas of DOCA-salt hypertensive mice. Preincubation with sepiapterin (10 μmol/l for 30 min) failed to improve NO bioavailability in hypertensive aortas while it augmented NO production from control vessels, implicating a hypertension-associated deficiency in sepiapterin reductase (SPR), the rate-limiting enzyme for sepiapterin conversion to H 4B. Indeed, a decreased SPR expression was observed in aortic endothelial cells, but not in endothelium-denuded aortic remains, implicating an endothelium-specific SPR deficiency. Administration of hypertensive aortas with H 4B (10 μmol/l, 30 min) partially restored vascular NO production. Combined administration of H 4B and the NADPH oxidase inhibitor apocynin (100 μmol/l, 30 min) fully restored NO bioavailability while reducing O 2 - production. In angiotensin II-induced hypertension, however, aortic endothelial SPR expression was not affected. In summary, administration of sepiapterin is not effective in recoupling eNOS in DOCA-salt hypertension, due to an endothelium-specific loss in SPR, whereas coadministration of H 4B and apocynin is highly efficient in recoupling eNOS. This is consistent with our previous observations that in angiotensin II hypertension, endothelial deficiency in dihydro-folate reductase is alternatively responsible for uncoupling of eNOS. Taken together, these data indicate that strategies specifically targeting at different H 4B metabolic enzymes might be necessary in restoring eNOS function in different types of hypertension.

AB - The endothelial nitric oxide synthase (eNOS) requires tetrahydrobiopterin (H 4B) as a cofactor and, in its absence, produces superoxide (O 2 -) rather than nitric oxide (NO), a condition referred to as eNOS uncoupling. DOCA-salt-induced hypertension is associated with H 4B oxidation and uncoupling of eNOS. The present study investigated whether administration of sepiapterin or H 4B recouples eNOS in DOCA-salt hypertension. Bioavailable NO detected by electron spin resonance was markedly reduced in aortas of DOCA-salt hypertensive mice. Preincubation with sepiapterin (10 μmol/l for 30 min) failed to improve NO bioavailability in hypertensive aortas while it augmented NO production from control vessels, implicating a hypertension-associated deficiency in sepiapterin reductase (SPR), the rate-limiting enzyme for sepiapterin conversion to H 4B. Indeed, a decreased SPR expression was observed in aortic endothelial cells, but not in endothelium-denuded aortic remains, implicating an endothelium-specific SPR deficiency. Administration of hypertensive aortas with H 4B (10 μmol/l, 30 min) partially restored vascular NO production. Combined administration of H 4B and the NADPH oxidase inhibitor apocynin (100 μmol/l, 30 min) fully restored NO bioavailability while reducing O 2 - production. In angiotensin II-induced hypertension, however, aortic endothelial SPR expression was not affected. In summary, administration of sepiapterin is not effective in recoupling eNOS in DOCA-salt hypertension, due to an endothelium-specific loss in SPR, whereas coadministration of H 4B and apocynin is highly efficient in recoupling eNOS. This is consistent with our previous observations that in angiotensin II hypertension, endothelial deficiency in dihydro-folate reductase is alternatively responsible for uncoupling of eNOS. Taken together, these data indicate that strategies specifically targeting at different H 4B metabolic enzymes might be necessary in restoring eNOS function in different types of hypertension.

KW - Deoxycorticosterone acetate

KW - Endothelial nitric oxide synthase uncoupling

KW - Nitric oxide

KW - Sepiapterin reductase

KW - Superoxide

KW - Tetrahydrobiopterin

KW - Vascular reduced nicotinamide adenine dinucleotide phosphatase

UR - http://www.scopus.com/inward/record.url?scp=84861783891&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861783891&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00835.2011

DO - 10.1152/ajpheart.00835.2011

M3 - Article

VL - 302

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6143

IS - 11

ER -